Association between Helicobacter pylori infection and Guillain-Barré Syndrome: A meta-analysis.
Helicobacter pylori
Guillain-Barré Syndrome
anti- H pylori IgG
antibodies
seropositivity
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
11
11
2019
revised:
31
01
2020
accepted:
27
02
2020
pubmed:
4
3
2020
medline:
24
3
2021
entrez:
4
3
2020
Statut:
ppublish
Résumé
Helicobacter pylori (H pylori) is a Gram-negative bacterium, considered to trigger autoimmune gastrointestinal disorders. This pathogen has also been linked to the autoimmune sequelae in extra-gastrointestinal diseases and peripheral neuropathies. Guillain-Barré syndrome (GBS) is a serious autoimmune demyelinating disorder of peripheral nerves, usually with a post-infectious onset. About 30% of cases of GBS attributed to by Campylobacter jejuni, so, H pylori, could be also involved. Growing evidence suggests the likely involvement of H pylori infection in the development of GBS. The aim of the current study was to therefore estimate the prevalence of H pylori antibodies in GBS. A search of the literature was performed, using the PUBMED database, until December 2018. Data were extracted from six case-control studies, and a stratification analysis was conducted according to cerebrospinal fluid (CSF) or serum detection material. Among 29 records found, 6 studies met in the inclusion criteria for the meta-analysis. In the CSF subgroup, 105 participants were involved (40 GBS patients and 65 controls), while the serum subgroup included 325 participants (152 GBS and 173 controls). Data were combined using a fixed-effects model. Anti-H pylori IgG were significantly more prevalent in GBS patients compared to controls, in both CSF (95% CI: 9.66-186.56, OR: 42.45, Pz < .00001) and serum (95% CI: 1.30-4.11, OR: 2.31, Pz: .004) subgroups. The present meta-analysis showed a strong association between GBS and the presence of H pylori antibodies, especially in CSF, thereby suggesting a role of H pylori infection in the pathophysiology of GBS.
Sections du résumé
BACKGROUND
BACKGROUND
Helicobacter pylori (H pylori) is a Gram-negative bacterium, considered to trigger autoimmune gastrointestinal disorders. This pathogen has also been linked to the autoimmune sequelae in extra-gastrointestinal diseases and peripheral neuropathies. Guillain-Barré syndrome (GBS) is a serious autoimmune demyelinating disorder of peripheral nerves, usually with a post-infectious onset. About 30% of cases of GBS attributed to by Campylobacter jejuni, so, H pylori, could be also involved. Growing evidence suggests the likely involvement of H pylori infection in the development of GBS. The aim of the current study was to therefore estimate the prevalence of H pylori antibodies in GBS.
METHODS
METHODS
A search of the literature was performed, using the PUBMED database, until December 2018. Data were extracted from six case-control studies, and a stratification analysis was conducted according to cerebrospinal fluid (CSF) or serum detection material.
RESULTS
RESULTS
Among 29 records found, 6 studies met in the inclusion criteria for the meta-analysis. In the CSF subgroup, 105 participants were involved (40 GBS patients and 65 controls), while the serum subgroup included 325 participants (152 GBS and 173 controls). Data were combined using a fixed-effects model. Anti-H pylori IgG were significantly more prevalent in GBS patients compared to controls, in both CSF (95% CI: 9.66-186.56, OR: 42.45, Pz < .00001) and serum (95% CI: 1.30-4.11, OR: 2.31, Pz: .004) subgroups.
CONCLUSION
CONCLUSIONS
The present meta-analysis showed a strong association between GBS and the presence of H pylori antibodies, especially in CSF, thereby suggesting a role of H pylori infection in the pathophysiology of GBS.
Substances chimiques
Antibodies, Bacterial
0
Immunoglobulin G
0
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13218Informations de copyright
© 2020 Stichting European Society for Clinical Investigation Journal Foundation.
Références
Amieva M, Peek RM Jr. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150(1):64-78.
Kao CY, Sheu BS, Wu JJ. Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis. Biomed J. 2016;39(1):14-23.
Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19(Suppl 1):1-5.
Mentis AA, Boziki M, Grigoriadis N, Papavassiliou AG. Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword. Cell Mol Life Sci. 2019;76(13):2477-2486.
Mentis AA, Dardiotis E. Helicobacter pylori Eradication for metachronous gastric cancer: an unsuitable methodology impeding broader clinical usage. Front Oncol. 2019;9:90.
Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol. 2014;20(3):613-629.
Franceschi F, Gasbarrini A, Polyzos SA, Kountouras J. Extragastric diseases and Helicobacter pylori. Helicobacter. 2015;20(Suppl 1):40-46.
Astl J, Sterzl I. Activation of Helicobacter pylori causes either autoimmune thyroid diseases or carcinogenesis in the digestive tract. Physiol Res. 2015;64(Suppl 2):S291-S301.
Deretzi G, Gavalas E, Boziki M, et al. Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome. Acta Neurolo Scand. 2016;133(4):268-275.
Choi YM, Kim TY, Kim EY, et al. Association between thyroid autoimmunity and Helicobacter pylori infection. Korean J Intern Med. 2017;32(2):309-313.
Dardiotis E, Tsouris Z, Mentis AA, et al. H. pylori and Parkinson’s disease: meta-analyses including clinical severity. Clin Neurol Neurosurg. 2018;175:16-24.
Kountouras J, Zavos C, Chatzopoulos D. Apoptosis and autoimmunity as proposed pathogenetic links between Helicobacter pylori infection and idiopathic achalasia. Med Hypotheses. 2004;63(4):624-629.
Chiba S, Sugiyama T, Yonekura K, et al. An antibody to VacA of Helicobacter pylori in the CSF of patients with Miller-Fisher syndrome. Neurology. 2004;63(11):2184-2186.
van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469-482.
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 388(10045), 717-727.
Dimachkie MM, Barohn RJ. Guillain-Barré Syndrome and Variants. Neurol Clin. 2013;31(2):491-510.
Zautner AE, Johann C, Strubel A, et al. Seroprevalence of campylobacteriosis and relevant post-infectious sequelae. Eur J Clin Microbiol Infect Dis. 2014;33(6):1019-1027.
Tolunay O, Çelik T, Çelik Ü, Kömür M, Tanyeli Z, Sönmezler A. Concurrency of Guillain-Barre syndrome and acute transverse myelitis: a case report and review of literature. Korean J Pediatr. 2016;59(Suppl 1):S161-S164.
Esposito S, Longo MR. Guillain-Barre syndrome. Autoimmun Rev. 2017;16(1):96-101.
Krauer F, Riesen M, Reveiz L, et al. Zika Virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: systematic review. PLoS Med. 2017;14(1):e1002203.
Annunziata P, Figura N, Galli R, Mugnaini F, Lenzi C. Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barre syndrome. J Neurol Sci. 2003;213(1-2):55-60.
Goodfellow JA, Willison HJ. Guillain-Barre syndrome: a century of progress. Nat Rev Neurol. 2016;12(12):723-731.
Álvarez-Arellano L, Maldonado-Bernal C Helicobacter pylori and neurological diseases: married by the laws of inflammation. World J Gastrointest Pathophysiol. 2014;5(4):400-404.
Chiba S, Sugiyama T, Matsumoto H, et al. Antibodies against Helicobacter pylori were detected in the cerebrospinal fluid obtained from patients with Guillain-Barre syndrome. Ann Neurol. 1998;44(4):686-688.
Chiba S, Sugiyama T, Yonekura K, et al. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid from patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2002;73(1):76-78.
Kountouras J, Deretzi G, Zavos C, et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2005;12(2):139-143.
Ghabaee M, Ghanbarian D, Brujeni GN, Bokaei S, Siavoshi F, Gharibzadeh S. Could Helicobacter pylori play an important role in axonal type of Guillain-Barre syndrome pathogenesis? Clin Neurol Neurosurg. 2010;112(3):193-198.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-748.
Siokas V, Dardiotis E, Tsironi EE, et al. The role of TOR1A polymorphisms in dystonia: a systematic review and meta-analysis. PloS One. 2017;12(1):e0169934.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Moran AP, Prendergast MM. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun. 2001;16(3):241-256.
Moran AP. The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni. Sub-cell Biochem. 2010;53:209-240.
Zhang M, Gilbert M, Yuki N, et al. Association of Anti-GT1a antibodies with an outbreak of Guillain-Barre syndrome and analysis of ganglioside mimicry in an associated Campylobacter jejuni strain. PloS One. 2015;10(7):e0131730.
Li H, Liao T, Debowski AW, et al. Lipopolysaccharide structure and biosynthesis in Helicobacter pylori. Helicobacter. 2016;21(6):445-461.
Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 1992;267(15):10570-10575.
Kountouras J, Zavos C, Deretzi G, et al. Potential implications of Helicobacter pylori-related neutrophil-activating protein. World J Gastroenterol. 2012;18(5):489-490.
Lilje O, Armati PJ. Restimulation of resting autoreactive T cells by Schwann cells in vitro. Exp Mol Pathol. 1999;67(3):164-174.
Kountouras J, Deretzi G, Zavos C, et al. Helicobacter pylori infection may trigger Guillain-Barre syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci. 2011;305(1-2):167-168; author reply 169.
Brown LF, Detmar M, Claffey K, et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Exs. 1997;79:233-269.
Parameswaran N, Patial S. Tumor necrosis factor-alpha signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87-103.
Gonzalez-Quevedo A, Carriera RF, O'Farrill ZL, Luis IS, Becquer RM, Luis Gonzalez RS. An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain Barre syndrome. Neurol India. 2009;57(3):288-294.
Yuki N, Shahrizaila N. How do we identify infectious agents that trigger Guillain-Barre syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis? J Neurol Sci. 2011;302(1-2):1-5.
Kountouras J, Deretzi G, Grigoriadis N, et al. Guillain-Barre syndrome. Lancet Neurol. 2008;7(12):1080-1081; author reply 1083-1085.
Kountouras J, Zavos C, Deretzi G, et al. Helicobacter pylori may play an important role in both axonal type Guillain-Barre syndrome and acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurol Neurosurg. 2011;113(6):520.
Kienesberger S, Cox LM, Livanos A, et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep. 2016;14(6):1395-1407.
Klymiuk I, Bilgilier C, Stadlmann A, et al. The human gastric microbiome is predicated upon infection with Helicobacter pylori. Front Microbiol. 2017;8:2508.
Noto JM, Peek RM Jr. The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog. 2017;13(10):e1006573.
Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects. World J Gastroenterol. 2018;24(28):3071-3089.
Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5(4):574-579.
Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716-1725.
Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the gastrointestinal tract. Microbes Environ. 2017;32(4):300-313.
Kho ZY, Lal SK. The human gut microbiome - a potential controller of wellness and disease. Front Microbiol. 2018;9:1835.
Roubaud-Baudron C, Megraud F, Salles N, Dartigues JF, Letenneur L. Detecting both current and prior Helicobacter pylori infection is important to assess its impact on dementia. Alzheimer's Dement. 2019;15(5):721-722.